Convalescent Plasma Research

Judith Aberg, MD, provides an overview on convalescent plasma research for the prevention and treatment of #COVID19. Dr. Aberg discusses the difference between convalescent plasma and hyperimmune globulin. She discusses some of the advantages of hyperimmune globulin, as well as the research being conducted at Mount Sinai to determine the most effective dosage and frequency, and whether it is an effective prophylaxis postexposure.


Related Presenters

Judith Aberg, MD.

Judith Aberg, MD

Dean of System Operations for Clinical Sciences
The Dr. George Baehr Professor of Clinical Medicine
Icahn School of Medicine at Mount Sinai
Chief of Infectious Diseases
Mount Sinai Health System

View full profile


Related Videos